XML 78 R138.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Condensed Consolidating Financial Information (Statements of Cash Flows) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities $ 124,071 $ 181,834 $ 131,586
Cash flows from investing activities:      
Sale of investment securities 21,879 18,628 28,761
Maturities of investment securities 68,859 24,719 101,097
Purchase of investment securities (87,766) (34,445) (132,654)
Proceeds from sale or liquidation of long-term investments 8,256 19,487 966
Purchase of long-term investments (9,223) (415) (32,510)
Investments in real estate ventures (52,529) (9,728) (38,807)
Distributions from investments in real estate ventures 41,300 54,233 61,718
Increase in cash surrender value of life insurance policies (719) (764) (802)
Decrease in restricted assets 994 526 2,250
Issuance of notes receivable 0 (450) (1,633)
Investments in subsidiaries 0 0 0
Proceeds from sale of fixed assets 17 9 76
Cash acquired in purchase of subsidiaries 0 654 0
Purchase of subsidiaries (380) (10,404) (6,569)
Repayments of notes receivable 0 67 0
Capital expenditures (12,575) (17,682) (19,869)
Investments in real estate, net (2,295) (2,583) (619)
Pay downs of investment securities 1,083 1,611 2,633
Net cash (used in) provided by investing activities (23,099) 43,463 (35,962)
Cash flows from financing activities:      
Proceeds from issuance of debt 230,000 325,000 850,021
Deferred financing costs (9,802) (9,400) (19,200)
Repayments of debt (293,419) (28,689) (837,205)
Borrowings under revolver 243,688 307,023 157,630
Repayments on revolver (239,526) (310,551) (163,474)
Capital contributions received 0 0 0
Intercompany dividends paid 0 0 0
Dividends and distributions on common stock (238,249) (225,367) (211,488)
Distributions to non-controlling interest (286) (2,521) (2,779)
Proceeds from exercise of Vector options     43,230
Tax withholdings related to net share settlements of stock option exercise (5,415) 0 0
Other (216) 0 0
Net cash (used in) provided by financing activities (313,225) 55,495 (183,265)
Net (decrease) increase in cash, cash equivalents and restricted cash (212,253) 280,792 (87,641)
Cash, cash equivalents and restricted cash, beginning of year 591,729 310,937 398,578
Cash and cash equivalents and restricted cash, end of year 379,476 591,729 310,937
Consolidating Adjustments      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities (268,611) (248,091) (275,997)
Cash flows from investing activities:      
Sale of investment securities 0 0 0
Maturities of investment securities 0 0 0
Purchase of investment securities 0 0 0
Proceeds from sale or liquidation of long-term investments 0 0 0
Purchase of long-term investments 0 0 0
Investments in real estate ventures 0 0 0
Distributions from investments in real estate ventures 0 0 0
Increase in cash surrender value of life insurance policies 0 0 0
Decrease in restricted assets 0 0 0
Issuance of notes receivable   0 20,000
Investments in subsidiaries 59,467 27,224 38,458
Proceeds from sale of fixed assets 0 0 0
Cash acquired in purchase of subsidiaries   0  
Purchase of subsidiaries 0 0 0
Repayments of notes receivable   (20,000)  
Capital expenditures 0 0 0
Investments in real estate, net 0 0 0
Pay downs of investment securities 0 0 0
Net cash (used in) provided by investing activities 59,467 7,224 58,458
Cash flows from financing activities:      
Proceeds from issuance of debt 0 0 (20,000)
Deferred financing costs 0 0 0
Repayments of debt 0 20,000 0
Borrowings under revolver 0 0 0
Repayments on revolver 0 0 0
Capital contributions received (59,467) (27,224) (38,458)
Intercompany dividends paid 268,611 248,091 275,997
Dividends and distributions on common stock 0 0 0
Distributions to non-controlling interest 0 0 0
Proceeds from exercise of Vector options     0
Tax withholdings related to net share settlements of stock option exercise 0    
Other 0    
Net cash (used in) provided by financing activities 209,144 240,867 217,539
Net (decrease) increase in cash, cash equivalents and restricted cash 0 0 0
Cash, cash equivalents and restricted cash, beginning of year 0 0 0
Cash and cash equivalents and restricted cash, end of year 0 0 0
Parent/Issuer | Reportable Legal Entities      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities 166,855 188,568 177,259
Cash flows from investing activities:      
Sale of investment securities 21,879 14,673 28,761
Maturities of investment securities 68,859 24,719 101,097
Purchase of investment securities (87,766) (34,445) (132,654)
Proceeds from sale or liquidation of long-term investments 8,256 19,487 500
Purchase of long-term investments (6,556) (415) (31,650)
Investments in real estate ventures 0 0 0
Distributions from investments in real estate ventures 0 0 0
Increase in cash surrender value of life insurance policies (235) (280) (318)
Decrease in restricted assets (29) 6 227
Issuance of notes receivable   0 (20,000)
Investments in subsidiaries (59,467) (17,224) (38,458)
Proceeds from sale of fixed assets 0 0 0
Cash acquired in purchase of subsidiaries   0  
Purchase of subsidiaries 0 0 0
Repayments of notes receivable   20,000  
Capital expenditures (126) (22) (35)
Investments in real estate, net 0 0 0
Pay downs of investment securities 1,083 1,611 2,633
Net cash (used in) provided by investing activities (54,102) 28,110 (89,897)
Cash flows from financing activities:      
Proceeds from issuance of debt 230,000 325,000 850,000
Deferred financing costs (9,297) (9,400) (19,200)
Repayments of debt (292,390) (26,750) (835,000)
Borrowings under revolver 0 0
Repayments on revolver 0 0 0
Capital contributions received 0 0 0
Intercompany dividends paid 0 0 0
Dividends and distributions on common stock (238,249) (225,367) (211,488)
Distributions to non-controlling interest 0 0 0
Proceeds from exercise of Vector options     43,230
Tax withholdings related to net share settlements of stock option exercise (5,415)    
Other 0    
Net cash (used in) provided by financing activities (315,351) 63,483 (172,458)
Net (decrease) increase in cash, cash equivalents and restricted cash (202,598) 280,161 (85,096)
Cash, cash equivalents and restricted cash, beginning of year 474,880 194,719 279,815
Cash and cash equivalents and restricted cash, end of year 272,282 474,880 194,719
Subsidiary Guarantors | Reportable Legal Entities      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities 219,173 204,638 171,122
Cash flows from investing activities:      
Sale of investment securities 0 3,955 0
Maturities of investment securities 0 0 0
Purchase of investment securities 0 0 0
Proceeds from sale or liquidation of long-term investments 0 0 0
Purchase of long-term investments 0 0 0
Investments in real estate ventures 0 0 0
Distributions from investments in real estate ventures 0 0 0
Increase in cash surrender value of life insurance policies (484) (484) (484)
Decrease in restricted assets 1,023 520 1,783
Issuance of notes receivable   0 0
Investments in subsidiaries 0 0 0
Proceeds from sale of fixed assets 8 9 76
Cash acquired in purchase of subsidiaries   0  
Purchase of subsidiaries 0 (10,000) 0
Repayments of notes receivable   0  
Capital expenditures (4,173) (4,599) (3,705)
Investments in real estate, net 0 0 0
Pay downs of investment securities 0 0 0
Net cash (used in) provided by investing activities (3,626) (10,599) (2,330)
Cash flows from financing activities:      
Proceeds from issuance of debt 0 0 20,000
Deferred financing costs (505) 0 0
Repayments of debt (820) (21,631) (1,882)
Borrowings under revolver 243,688 307,023 157,630
Repayments on revolver (239,526) (310,551) (163,474)
Capital contributions received 1,225 10,800 2,400
Intercompany dividends paid (215,728) (176,006) (182,975)
Dividends and distributions on common stock 0 0 0
Distributions to non-controlling interest 0 0 0
Proceeds from exercise of Vector options     0
Tax withholdings related to net share settlements of stock option exercise 0    
Other 0    
Net cash (used in) provided by financing activities (211,666) (190,365) (168,301)
Net (decrease) increase in cash, cash equivalents and restricted cash 3,881 3,674 491
Cash, cash equivalents and restricted cash, beginning of year 23,849 20,175 19,684
Cash and cash equivalents and restricted cash, end of year 27,730 23,849 20,175
Subsidiary Non-Guarantors | Reportable Legal Entities      
Condensed Financial Statements, Captions [Line Items]      
Net cash provided by operating activities 6,654 36,719 59,202
Cash flows from investing activities:      
Sale of investment securities 0 0 0
Maturities of investment securities 0 0 0
Purchase of investment securities 0 0 0
Proceeds from sale or liquidation of long-term investments 0 0 466
Purchase of long-term investments (2,667) 0 (860)
Investments in real estate ventures (52,529) (9,728) (38,807)
Distributions from investments in real estate ventures 41,300 54,233 61,718
Increase in cash surrender value of life insurance policies 0 0 0
Decrease in restricted assets 0 0 240
Issuance of notes receivable   (450) (1,633)
Investments in subsidiaries 0 (10,000) 0
Proceeds from sale of fixed assets 9 0 0
Cash acquired in purchase of subsidiaries   654  
Purchase of subsidiaries (380) (404) (6,569)
Repayments of notes receivable   67  
Capital expenditures (8,276) (13,061) (16,129)
Investments in real estate, net (2,295) (2,583) (619)
Pay downs of investment securities 0 0 0
Net cash (used in) provided by investing activities (24,838) 18,728 (2,193)
Cash flows from financing activities:      
Proceeds from issuance of debt 0 0 21
Deferred financing costs 0 0 0
Repayments of debt (209) (308) (323)
Borrowings under revolver 0 0 0
Repayments on revolver 0 0 0
Capital contributions received 58,242 16,424 36,058
Intercompany dividends paid (52,883) (72,085) (93,022)
Dividends and distributions on common stock 0 0 0
Distributions to non-controlling interest (286) (2,521) (2,779)
Proceeds from exercise of Vector options     0
Tax withholdings related to net share settlements of stock option exercise 0    
Other (216)    
Net cash (used in) provided by financing activities 4,648 (58,490) (60,045)
Net (decrease) increase in cash, cash equivalents and restricted cash (13,536) (3,043) (3,036)
Cash, cash equivalents and restricted cash, beginning of year 93,000 96,043 99,079
Cash and cash equivalents and restricted cash, end of year $ 79,464 $ 93,000 $ 96,043